Lonnie Zwaigenbaum1, Gregory S Young2, Wendy L Stone3, Karen Dobkins4, Sally Ozonoff2, Jessica Brian5, Susan E Bryson6, Leslie J Carver4, Ted Hutman7, Jana M Iverson8, Rebecca J Landa9, Daniel Messinger10. 1. University of Alberta, Edmonton, Alberta, Canada. Electronic address: lonniez@ualberta.ca. 2. University of California, Davis. 3. University of Washington, Seattle. 4. University of California, San Diego. 5. University of Toronto, Ontario, Canada. 6. Dalhousie University, Halifax, Nova Scotia, Canada. 7. University of California, Los Angeles. 8. University of Pittsburgh. 9. Kennedy Krieger Institute and Johns Hopkins School of Medicine, Baltimore. 10. University of Miami.
Abstract
OBJECTIVE: Although early brain overgrowth is frequently reported in autism spectrum disorder (ASD), the relationship between ASD and head circumference (HC) is less clear, with inconsistent findings from longitudinal studies that include community controls. Our aim was to examine whether head growth in the first 3 years differed between children with ASD from a high-risk (HR) sample of infant siblings of children with ASD (by definition, multiplex), HR siblings not diagnosed with ASD, and low-risk (LR) controls. METHOD: Participants included 442 HR and 253 LR infants from 12 sites of the international Baby Siblings Research Consortium. Longitudinal HC data were obtained prospectively, supplemented by growth records. Random effects nonlinear growth models were used to compare HC in HR infants and LR infants. Additional comparisons were conducted with the HR group stratified by diagnostic status at age 3: ASD (n = 77), developmental delay (DD; n = 32), and typical development (TD; n = 333). Nonlinear growth models were also developed for height to assess general overgrowth associated with ASD. RESULTS: There was no overall difference in head circumference growth over the first 3 years between HR and LR infants, although secondary analyses suggested possible increased total growth in HR infants, reflected by the model asymptote. Analyses stratifying the HR group by 3-year outcomes did not detect differences in head growth or height between HR infants who developed ASD and those who did not, nor between infants with ASD and LR controls. CONCLUSION: Head growth was uninformative as an ASD risk marker within this HR cohort.
OBJECTIVE: Although early brain overgrowth is frequently reported in autism spectrum disorder (ASD), the relationship between ASD and head circumference (HC) is less clear, with inconsistent findings from longitudinal studies that include community controls. Our aim was to examine whether head growth in the first 3 years differed between children with ASD from a high-risk (HR) sample of infant siblings of children with ASD (by definition, multiplex), HR siblings not diagnosed with ASD, and low-risk (LR) controls. METHOD:Participants included 442 HR and 253 LR infants from 12 sites of the international Baby Siblings Research Consortium. Longitudinal HC data were obtained prospectively, supplemented by growth records. Random effects nonlinear growth models were used to compare HC in HR infants and LR infants. Additional comparisons were conducted with the HR group stratified by diagnostic status at age 3: ASD (n = 77), developmental delay (DD; n = 32), and typical development (TD; n = 333). Nonlinear growth models were also developed for height to assess general overgrowth associated with ASD. RESULTS: There was no overall difference in head circumference growth over the first 3 years between HR and LR infants, although secondary analyses suggested possible increased total growth in HR infants, reflected by the model asymptote. Analyses stratifying the HR group by 3-year outcomes did not detect differences in head growth or height between HR infants who developed ASD and those who did not, nor between infants with ASD and LR controls. CONCLUSION: Head growth was uninformative as an ASD risk marker within this HR cohort.
Authors: E Courchesne; C M Karns; H R Davis; R Ziccardi; R A Carper; Z D Tigue; H J Chisum; P Moses; K Pierce; C Lord; A J Lincoln; S Pizzo; L Schreibman; R H Haas; N A Akshoomoff; R Y Courchesne Journal: Neurology Date: 2001-07-24 Impact factor: 9.910
Authors: Robert J Kuczmarski; Cynthia L Ogden; Shumei S Guo; Laurence M Grummer-Strawn; Katherine M Flegal; Zuguo Mei; Rong Wei; Lester R Curtin; Alex F Roche; Clifford L Johnson Journal: Vital Health Stat 11 Date: 2002-05
Authors: B F Sparks; S D Friedman; D W Shaw; E H Aylward; D Echelard; A A Artru; K R Maravilla; J N Giedd; J Munson; G Dawson; S R Dager Journal: Neurology Date: 2002-07-23 Impact factor: 9.910
Authors: Gajendra J Katuwal; Stefi A Baum; Nathan D Cahill; Chase C Dougherty; Eli Evans; David W Evans; Gregory J Moore; Andrew M Michael Journal: Front Neurosci Date: 2016-09-30 Impact factor: 4.677